These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17371266)

  • 1. Metabolic enzymes regulated by the Myc oncogene are possible targets for chemotherapy or chemoprevention.
    Rimpi S; Nilsson JA
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):305-10. PubMed ID: 17371266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mnt takes control as key regulator of the myc/max/mxd network.
    Wahlström T; Henriksson M
    Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Myc oncoprotein as a therapeutic target for human cancer.
    Vita M; Henriksson M
    Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc pathways provoking cell suicide and cancer.
    Nilsson JA; Cleveland JL
    Oncogene; 2003 Dec; 22(56):9007-21. PubMed ID: 14663479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer therapeutics: targeting the dark side of Myc.
    Ponzielli R; Katz S; Barsyte-Lovejoy D; Penn LZ
    Eur J Cancer; 2005 Nov; 41(16):2485-501. PubMed ID: 16243519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line.
    Schlosser I; Hölzel M; Hoffmann R; Burtscher H; Kohlhuber F; Schuhmacher M; Chapman R; Weidle UH; Eick D
    Oncogene; 2005 Jan; 24(3):520-4. PubMed ID: 15516975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is oncogene addiction angiogenesis-dependent?
    Folkman J; Ryeom S
    Cold Spring Harb Symp Quant Biol; 2005; 70():389-97. PubMed ID: 16869776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The c-myc promoter: still MysterY and challenge.
    Wierstra I; Alves J
    Adv Cancer Res; 2008; 99():113-333. PubMed ID: 18037408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MYC-WDR5 Nexus and Cancer.
    Thomas LR; Foshage AM; Weissmiller AM; Tansey WP
    Cancer Res; 2015 Oct; 75(19):4012-5. PubMed ID: 26383167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of DNA repair in hypoxic cancer cells.
    Bindra RS; Crosby ME; Glazer PM
    Cancer Metastasis Rev; 2007 Jun; 26(2):249-60. PubMed ID: 17415527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamics of b-HLH-LZ protein binding to DNA: the energetic importance of protein-DNA contacts in site-specific E-box recognition by the complete gene product of the Max p21 transcription factor.
    Meier-Andrejszki L; Bjelić S; Naud JF; Lavigne P; Jelesarov I
    Biochemistry; 2007 Oct; 46(43):12427-40. PubMed ID: 17915948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drosophila Myc.
    Gallant P
    Adv Cancer Res; 2009; 103():111-44. PubMed ID: 19854354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained loss of a neoplastic phenotype by brief inactivation of MYC.
    Jain M; Arvanitis C; Chu K; Dewey W; Leonhardt E; Trinh M; Sundberg CD; Bishop JM; Felsher DW
    Science; 2002 Jul; 297(5578):102-4. PubMed ID: 12098700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.
    Pelengaris S; Khan M
    Expert Opin Ther Targets; 2003 Oct; 7(5):623-42. PubMed ID: 14498825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
    Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences.
    Montagne M; Naud JF; Lavigne P
    J Mol Biol; 2008 Feb; 376(1):141-52. PubMed ID: 18155722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
    Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
    Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The great MYC escape in tumorigenesis.
    Dang CV; O'donnell KA; Juopperi T
    Cancer Cell; 2005 Sep; 8(3):177-8. PubMed ID: 16169462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.